LiveNova Logo

TandemLife is now a part of LivaNova, Learn More Here.

COVID-19 UPDATES:The U.S. Food and Drug Administration (FDA) issued guidance on April 6, 2020 to temporarily expand the availability of devices used in extracorporeal membrane oxygenation (ECMO) therapy to address the novel coronavirus (COVID-19) public health emergency. As a result of the guidance, cardiopulmonary devices, including select devices from TandemLife | LivaNova, are now temporarily indicated for ECMO therapy greater than 6 hours. To read the full announcement, click here.

MENU

412 963 7770 GENERAL INFORMATION

855 336 3051 REIMBURSEMENT

800 373 1607 US

412 507 6182 INTERNATIONAL

Careers

Exciting news, TandemLife is officially a part of LivaNova.  

To learn more about opportunities to join our team, visit our careers page.

We look forward to hearing from you.